should not be used for treatment of PIH would seem to apply equally in ENT and ophthalmic theatres.
However, those recommendations relating to phenylephrine concentration and dose appear to be speci®cally relevant to ENT surgery. The weakest commercially available ocular phenylephrine preparation is 2.5%. It is doubtful whether a 10-fold reduction in phenylephrine concentration would result in clinically useful pupillary dilatation. Had our surgeons used 2.5% rather than 10% phenylephrine, in keeping with the British National Formulary (BNF) recommendation 4 we cited in our case report, the dose administered to our patient would still have been more than ®ve times greater than the initial dose of 20 mg kg ±1 suggested in the New York State Guidelines.
Presumably ocular doses of this magnitude are widely deemed acceptable because phenylephrine absorption from the intact conjunctiva and nasolacrimal duct is much less than would be expected from a bleeding adenoidectomy site. In our view, the most signi®cant factor leading to excessive phenylephrine absorption in our patient was the short interval between application of the eyedrops and the conjunctival incision. Had the eyedrops been administered as prescribed, preoperatively on the ward, the complication may not have occurred. Other general preventative strategies speci®cally applicable to ophthalmic surgery were discussed in our article.
As regards a possible role for oxymetazoline, ocular phenylephrine is used to effect mydriasis rather than vasoconstriction. It is the only sympathomimetic listed for this purpose in the BNF and we are unaware of an appropriate alternative. The demands on the ICU are highly competitive and the elective, or even the emergency surgical, patient prioritizes poorly against other urgent or medical admissions. In our experience, the development of another existing resource, namely the recovery ward/postoperative care unit, together with the extended role of the recovery nurses, has made a signi®cant impact on reducing operative cancellation rates and waiting times for surgical procedures requiring critical care.
A. Morley London, UK
Another major advantage of providing short-term intensive care in a developed recovery facility (OIR) is to alleviate that demand on the ICU service and therefore increase total critical care provision within an individual hospital trust. The continuum of critical care in our trust, for example, includes the elements of the ICU, HDUs and the OIR.
I agree with Jones and Harper (and Ziser and his colleagues 3 ) who are quite correct to point out the disadvantages and dangers in the inappropriate use of an ordinary recovery ward as either an ICU over¯ow unit or an ill-equipped area pressured into providing postoperative ventilation. The formal development of beds and staf®ng within recovery to OIR or POCCU standards is essential to achieve safe critical care for the surgical patient. 4 We prefer the term Overnight Intensive Recovery as it is descriptive of the duration, function and geography of the facility. It is crucial to persuade others that this is for postoperative surgical patients only, and that it occurs in a theatre recovery ward staffed by (trained and supervised) recovery nurses and supported by anaesthetic medical staff. Although in this context critical care is probably a better term than intensive care, it has to be accepted that this OIR activity will require a 1:1 nurse:patient ratio in order to manage ventilated patients, invasive monitoring and pharmacological support.
I do take gentle issue with Jones and Harper in their assertion that the development of the OIR at St Thomas' (and more recently at Guy's) Hospital, London was only for cardiac surgical patients. It should be emphasized that cardiac surgery is not a necessary ingredient in the development of OIR beds. However, whilst it is absolutely true that the original development of cardiac fasttracking at St Thomas', and the use of the recovery ward for their postoperative management in the early 1980s, 5 led to the development of the OIR, its function then, and now, also includes a signi®cant non-cardiac workload. Currently, the annual throughput of both OIRs is around 300 non-cardiac patients, elective and emergency, from a wide number of specialties in addition to the cardiac surgical workload. Finally, our OIRs were created within rather than`adjacent to' the recovery wards, which emphasizes the ef®ciencies in staf®ng and supervision that are achieved when both general recovery and OIR areas are integral to one another. 
